Non-alcoholic fatty liver disease: identical etiologic factors in patients with type 1 and type 2 diabetes
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Non-alcoholic fatty liver disease: identical etiologic factors in patients with type 1 and type 2 diabetes
Authors
Keywords
Non-alcoholic fatty liver disease, NAFLD, Type 1 diabetes, Type 2 diabetes, Advanced fibrosis, Insulin resistance
Journal
European Journal of Internal Medicine
Volume 100, Issue -, Pages 77-82
Publisher
Elsevier BV
Online
2022-04-04
DOI
10.1016/j.ejim.2022.03.025
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Relationship Between Body Fat Distribution and Nonalcoholic Fatty Liver in Adults With Type 1 Diabetes
- (2021) Erika B. Parente et al. DIABETES CARE
- Non-alcoholic fatty liver disease: a multidisciplinary approach towards a cardiometabolic liver disease
- (2020) Merel M Ruissen et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
- (2020) Marieke de Vries et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes
- (2020) Stefano Ciardullo et al. DIABETES CARE
- Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening
- (2020) Romina Lomonaco et al. DIABETES CARE
- Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes
- (2019) E. Cipponeri et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2019) Peter J. Eddowes et al. GASTROENTEROLOGY
- Daily aspirin use associated with reduced risk for fibrosis progression in patients with nonalcoholic fatty liver disease
- (2019) Tracey G. Simon et al. Clinical Gastroenterology and Hepatology
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease in adults: Current concepts in etiology, outcomes and management
- (2019) Thomas Marjot et al. ENDOCRINE REVIEWS
- Prevalence and clinical characteristics of non-alcoholic fatty liver disease in newly diagnosed patients with ketosis-onset diabetes
- (2018) T.-T. Li et al. DIABETES & METABOLISM
- Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes
- (2017) Laura Sviklāne et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Metabolic consequences of adipose tissue dysfunction and not adiposity per se increase the risk of cardiovascular events and mortality in patients with type 2 diabetes
- (2016) Bas T. Franssens et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease
- (2016) Obesity Facts
- Type 1 diabetes is not associated with an increased prevalence of hepatic steatosis
- (2015) J.-M. Petit et al. DIABETIC MEDICINE
- Insulin resistance in patients with type 1 diabetes assessed by glucose clamp studies: systematic review and meta-analysis
- (2015) E. Donga et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
- (2015) Mattias Ekstedt et al. HEPATOLOGY
- Liver Fat Content and Hepatic Insulin Sensitivity in Overweight Patients With Type 1 Diabetes
- (2015) Gemma Llauradó et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinical Profile of Non Alcoholic Fatty Liver Disease Among Young Patients with Type 1 Diabetes Mellitus Seen at a Diabetes Speciality Centre in India
- (2014) Ramanujam Vendhan et al. Endocrine Practice
- Prevalence and natural history of histologically proven chronic liver disease in a longitudinal cohort of patients with type 1 diabetes
- (2014) David J. Harman et al. HEPATOLOGY
- Use of the Estimated Glucose Disposal Rate as a Measure of Insulin Resistance in an Urban Multiethnic Population With Type 1 Diabetes
- (2013) E. J. Epstein et al. DIABETES CARE
- The Diabetes Pearl: Diabetes biobanking in The Netherlands
- (2012) Esther van’t Riet et al. BMC PUBLIC HEALTH
- Screening for liver fibrosis by using FibroScan® and FibroTest in patients with diabetes
- (2012) Victor de Lédinghen et al. DIGESTIVE AND LIVER DISEASE
- Development, validation and use of an insulin sensitivity score in youths with diabetes: the SEARCH for Diabetes in Youth study
- (2010) D. Dabelea et al. DIABETOLOGIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search